Health In Tech (NASDAQ:HIT - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report issued on Saturday.
Separately, Maxim Group raised Health In Tech to a "strong-buy" rating and set a $2.50 price target on the stock in a research report on Thursday, June 26th.
Get Our Latest Research Report on Health In Tech
Health In Tech Stock Performance
Health In Tech stock opened at $1.84 on Friday. The business has a fifty day moving average of $0.86 and a two-hundred day moving average of $2.39. Health In Tech has a twelve month low of $0.51 and a twelve month high of $7.59.
Health In Tech (NASDAQ:HIT - Get Free Report) last posted its earnings results on Monday, July 21st. The company reported $0.01 earnings per share for the quarter, hitting analysts' consensus estimates of $0.01. The company had revenue of $9.31 million for the quarter, compared to analysts' expectations of $7.96 million.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC purchased a new position in Health In Tech in the 1st quarter valued at about $48,000. Cubist Systematic Strategies LLC purchased a new position in Health In Tech in the 1st quarter valued at about $41,000. Arete Wealth Advisors LLC purchased a new position in Health In Tech in the 1st quarter worth approximately $47,000. Finally, XTX Topco Ltd purchased a new position in Health In Tech in the 1st quarter worth approximately $59,000.
Health In Tech Company Profile
(
Get Free Report)
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Health In Tech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health In Tech wasn't on the list.
While Health In Tech currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.